Cutler Group LLC / CA - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$133,000
+1230.0%
5,000
+900.0%
0.01%
+500.0%
Q3 2020$10,000
-9.1%
5000.0%0.00%0.0%
Q2 2020$11,000
+37.5%
5000.0%0.00%
Q1 2020$8,000
-27.3%
5000.0%0.00%
-100.0%
Q4 2019$11,000
-15.4%
5000.0%0.00%0.0%
Q3 2019$13,000
-18.8%
5000.0%0.00%0.0%
Q2 2019$16,000
-5.9%
5000.0%0.00%
-50.0%
Q1 2019$17,000
-80.9%
500
-81.5%
0.00%
-75.0%
Q4 2018$89,000
+4350.0%
2,700
-18.2%
0.01%
Q1 2018$2,000
-77.8%
3,300
-0.4%
0.00%
Q4 2017$9,000
-96.6%
3,312
-73.4%
0.00%
-100.0%
Q3 2017$268,000
+14.0%
12,437
+45.0%
0.01%
+11.1%
Q2 2017$235,000
+197.5%
8,577
-15.1%
0.01%
+200.0%
Q1 2017$79,00010,100
+818.2%
0.00%
Q4 2016$0
-100.0%
1,100
-56.0%
0.00%
Q3 2016$8,000
-55.6%
2,500
-14.0%
0.00%
-100.0%
Q2 2016$18,000
-83.5%
2,906
-80.6%
0.00%
-85.7%
Q1 2016$109,000
-60.9%
15,006
-36.6%
0.01%
-53.3%
Q4 2015$279,00023,6840.02%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HealthInvest Partners AB 335,000$8,934,00013.38%
ASHFORD CAPITAL MANAGEMENT INC 1,016,665$27,114,0002.46%
Bruce & Co., Inc. 402,105$10,724,0002.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 297,500$7,934,0001.91%
ARMISTICE CAPITAL, LLC 3,900,000$104,013,0001.76%
Bridge City Capital, LLC 108,884$2,904,0001.32%
S&T BANK/PA 316,098$8,430,0001.31%
Kent Lake Capital LLC 100,000$2,667,0001.15%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 331,140$8,832,0001.02%
Prairiewood Capital, LLC 45,297$1,208,0000.99%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders